APPLICATION
ANDA076591
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-18
LATEST ACTION
2020-04-03
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
MOMETASONE FUROATEDiscontinued
MOMETASONE FUROATE 0.1% · CREAM · TOPICAL
Approval history
2020-04-03Labeling · Supplement 14 · standardAP
2015-10-29Labeling · Supplement 10 · standardAP
2012-11-30Labeling · Supplement 9 · standardAP
2007-04-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.